Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2015762875
Up to date per 12.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015762875
Title / Product Name
KRISTALLINES (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL)-3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPAN-1,2-DIOL
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015762875
EP Publication Number
3189044
E-Number
1024140
Language
EN
PCT Number
US15047415
Publication Date
12.07.2017 A
01.08.2018 B1
Registration Date
01.08.2018
AT Publication Date
15.08.2018
Application Date
28.08.2015
Registration Number
-
Priorities
04.09.2014
WO
PCT/CN2014/085925
IPC
C07D 401/14 20060101AFI20160316BHEP
Maximum Duration of Protection
28.08.2035
Owner
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
US
Representative
No representatives present
Inventor
HUANG, Ping
c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
RIBE, Seth Dietrich
c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
see.ip - Details for KRISTALLINES (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL)-3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPAN-1,2-DIOL